1. Home
  2. NMRA vs PCYO Comparison

NMRA vs PCYO Comparison

Compare NMRA & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • PCYO
  • Stock Information
  • Founded
  • NMRA 2019
  • PCYO 1976
  • Country
  • NMRA United States
  • PCYO United States
  • Employees
  • NMRA N/A
  • PCYO N/A
  • Industry
  • NMRA
  • PCYO Water Supply
  • Sector
  • NMRA
  • PCYO Utilities
  • Exchange
  • NMRA Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • NMRA 287.6M
  • PCYO 271.7M
  • IPO Year
  • NMRA 2023
  • PCYO N/A
  • Fundamental
  • Price
  • NMRA $1.80
  • PCYO $11.49
  • Analyst Decision
  • NMRA Strong Buy
  • PCYO
  • Analyst Count
  • NMRA 6
  • PCYO 0
  • Target Price
  • NMRA $20.67
  • PCYO N/A
  • AVG Volume (30 Days)
  • NMRA 2.0M
  • PCYO 35.5K
  • Earning Date
  • NMRA 03-06-2025
  • PCYO 04-09-2025
  • Dividend Yield
  • NMRA N/A
  • PCYO N/A
  • EPS Growth
  • NMRA N/A
  • PCYO 103.72
  • EPS
  • NMRA N/A
  • PCYO 0.55
  • Revenue
  • NMRA N/A
  • PCYO $29,113,000.00
  • Revenue This Year
  • NMRA N/A
  • PCYO N/A
  • Revenue Next Year
  • NMRA N/A
  • PCYO N/A
  • P/E Ratio
  • NMRA N/A
  • PCYO $20.89
  • Revenue Growth
  • NMRA N/A
  • PCYO 56.25
  • 52 Week Low
  • NMRA $1.60
  • PCYO $8.94
  • 52 Week High
  • NMRA $21.00
  • PCYO $14.63
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 27.76
  • PCYO 43.48
  • Support Level
  • NMRA $1.61
  • PCYO $11.23
  • Resistance Level
  • NMRA $1.80
  • PCYO $12.25
  • Average True Range (ATR)
  • NMRA 0.11
  • PCYO 0.28
  • MACD
  • NMRA 0.23
  • PCYO 0.03
  • Stochastic Oscillator
  • NMRA 51.28
  • PCYO 25.49

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: